Ameritas Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.17M | Sell |
12,422
-141
| -1% | -$62.5K | 0.16% | 96 |
|
|
2026
Q1 | $5.61M | Sell |
12,563
-2,618
| -17% | -$1.22M | 0.17% | 88 |
|
|
2025
Q4 | $6.88M | Buy |
15,181
+350
| +2% | +$151K | 0.21% | 77 |
|
|
2025
Q3 | $5.81M | Sell |
14,831
-78
| -0.5% | -$32.6K | 0.18% | 87 |
|
|
2025
Q2 | $6.64M | Sell |
14,909
-1,110
| -7% | -$512K | 0.21% | 66 |
|
|
2025
Q1 | $7.77M | Buy |
16,019
+117
| +0.7% | +$54.5K | 0.27% | 55 |
|
|
2024
Q4 | $6.4M | Buy |
15,902
+162
| +1% | +$75.1K | 0.21% | 62 |
|
|
2024
Q3 | $7.32M | Sell |
15,740
-706
| -4% | -$339K | 0.24% | 56 |
|
|
2024
Q2 | $7.71M | Sell |
16,446
-63
| -0.4% | -$27.3K | 0.26% | 48 |
|
|
2024
Q1 | $6.9M | Sell |
16,509
-106
| -0.6% | -$44.8K | 0.24% | 56 |
|
|
2023
Q4 | $6.76M | Sell |
16,615
-88
| -0.5% | -$32.5K | 0.25% | 53 |
|
|
2023
Q3 | $5.81M | Buy |
16,703
+856
| +5% | +$299K | 0.23% | 57 |
|
|
2023
Q2 | $5.58M | Sell |
15,847
-671
| -4% | -$226K | 0.21% | 68 |
|
|
2023
Q1 | $5.2M | Buy |
16,518
+26
| +0.2% | +$7.8K | 0.21% | 73 |
|
|
2022
Q4 | $4.96M | Sell |
16,492
-583
| -3% | -$178K | 0.2% | 81 |
|
|
2022
Q3 | $4.94M | Sell |
17,075
-229
| -1% | -$65.9K | 0.22% | 70 |
|
|
2022
Q2 | $4.87M | Sell |
17,304
-2
| -0% | -$535 | 0.21% | 73 |
|
|
2022
Q1 | $4.51M | Sell |
17,306
-151
| -0.9% | -$35.8K | 0.16% | 101 |
|
|
2021
Q4 | $3.83M | Sell |
17,457
-252
| -1% | -$49K | 0.13% | 138 |
|
|
2021
Q3 | $3.21M | Buy |
17,709
+161
| +0.9% | +$31.4K | 0.12% | 155 |
|
|
2021
Q2 | $3.54M | Sell |
17,548
-76
| -0.4% | -$15.9K | 0.13% | 139 |
|
|
2021
Q1 | $3.9M | Sell |
17,624
-64
| -0.4% | -$14.1K | 0.15% | 112 |
|
|
2020
Q4 | $4.18M | Sell |
17,688
-142
| -0.8% | -$32.6K | 0.19% | 84 |
|
|
2020
Q3 | $4.85M | Sell |
17,830
-411
| -2% | -$113K | 0.22% | 67 |
|
|
2020
Q2 | $5.29M | Sell |
18,241
-8
| -0% | -$2.17K | 0.25% | 58 |
|
|
2020
Q1 | $4.34M | Sell |
18,249
-1,449
| -7% | -$332K | 0.25% | 66 |
|
|
2019
Q4 | $4.31M | Buy |
19,698
+2,559
| +15% | +$518K | 0.19% | 74 |
|
|
2019
Q3 | $2.9M | Buy |
17,139
+7,849
| +84% | +$1.39M | 0.13% | 144 |
|
|
2019
Q2 | $1.7M | Sell |
9,290
-63
| -0.7% | -$11K | 0.08% | 286 |
|
|
2019
Q1 | $1.72M | Buy |
9,353
+108
| +1% | +$19.9K | 0.08% | 278 |
|
|
2018
Q4 | $1.53M | Buy |
9,245
+67
| +0.7% | +$11.6K | 0.08% | 282 |
|
|
2018
Q3 | $1.77M | Sell |
9,178
-265
| -3% | -$47.2K | 0.08% | 294 |
|
|
2018
Q2 | $1.6M | Sell |
9,443
-347
| -4% | -$53.8K | 0.08% | 320 |
|
|
2018
Q1 | $1.6M | Sell |
9,790
-296
| -3% | -$48.3K | 0.08% | 330 |
|
|
2017
Q4 | $1.51M | Sell |
10,086
-78
| -0.8% | -$11.5K | 0.07% | 369 |
|
|
2017
Q3 | $1.63M | Hold |
10,164
| – | – | 0.08% | 319 |
|
|
2017
Q2 | $1.31M | Hold |
10,164
| – | – | 0.06% | 408 |
|
|
2017
Q1 | $1.11M | Sell |
10,164
-208
| -2% | -$18.3K | 0.06% | 471 |
|
|
2016
Q4 | $764K | Hold |
10,372
| – | – | 0.04% | 618 |
|
|
2016
Q3 | $905K | Buy |
10,372
+1,117
| +12% | +$106K | 0.05% | 529 |
|
|
2016
Q2 | $796K | Buy |
9,255
+499
| +6% | +$43.1K | 0.05% | 384 |
|
|
2016
Q1 | $696K | Buy |
8,756
+58
| +0.7% | +$5.25K | 0.05% | 432 |
|
|
2015
Q4 | $1.09M | Buy |
8,698
+78
| +0.9% | +$9.42K | 0.07% | 267 |
|
|
2015
Q3 | $898K | Buy |
8,620
+78
| +0.9% | +$10K | 0.06% | 305 |
|
|
2015
Q2 | $1.05M | Buy |
8,542
+78
| +0.9% | +$9.83K | 0.07% | 287 |
|
|
2015
Q1 | $998K | Sell |
8,464
-7,171
| -46% | -$859K | 0.07% | 304 |
|
|
2014
Q4 | $1.86M | Buy |
15,635
+272
| +2% | +$30.6K | 0.13% | 172 |
|
|
2014
Q3 | $1.73M | Sell |
15,363
-612
| -4% | -$58.3K | 0.12% | 192 |
|
|
2014
Q2 | $1.51M | Sell |
15,975
-355
| -2% | -$24.9K | 0.11% | 214 |
|
|
2014
Q1 | $1.16M | Sell |
16,330
-227
| -1% | -$18K | 0.09% | 258 |
|
|
2013
Q4 | $1.23M | Buy |
16,557
+4,529
| +38% | +$315K | 0.1% | 248 |
|
|
2013
Q3 | $912K | Buy |
12,028
+3,528
| +42% | +$281K | 0.09% | 290 |
|
|
2013
Q2 | $681K | Buy |
+8,500
| New | +$626K | 0.19% | 197 |
|
Other funds holding VRTX
Ameritas Investment Partners's VRTX Position: Q2 2026 in Review
Ameritas Investment Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, selling an estimated $62.5K and leaving 12,422 shares worth $6.17M. The position accounts for 0.16% of the portfolio, ranked #96.
Ameritas Investment Partners first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.77M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ameritas Investment Partners held 12,422 shares of Vertex Pharmaceuticals worth $6.17M as of Q2 2026.
- Ameritas Investment Partners sold 141 Vertex Pharmaceuticals shares in Q2 2026, an estimated $62.5K.
- Vertex Pharmaceuticals made up 0.16% of Ameritas Investment Partners's portfolio in Q2 2026, its #96 holding.
- Ameritas Investment Partners first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Ameritas Investment Partners's Vertex Pharmaceuticals position peaked at $7.77M in Q1 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.